Diaverum expands its reach in Greece, through strategic partnership with BIOIATRIKI Healthcare Group
The Sweden-based, global renal care provider Diaverum is delighted to announce its further expansion into Greece, having entered into a strategic partnership with the renowned provider, BIOIATRIKI Healthcare Group.
Earlier this year, Diaverum announced its vision to transform renal care in Greece. Having already acquired six clinics, the company has established a significant presence in the country, positioning itself as the third-largest provider in the dialysis care sector.
Signed on 26 November, the partnership initiates a ten-year collaboration between Diaverum and BIOIATRIKI Healthcare Group, a leader in private healthcare services in Greece and the wider Mediterranean region, with over 43 years of experience in the sector.
The collaboration involves the implementation of Diaverum’s Care Delivery Model, supported by industry-leading, state-of-the-art technologies and an AI digital suite at the Group’s clinics, Bioclinic Athens and Bioclinic Thessaloniki. It aims to provide life-enhancing renal care underpinned by digital technologies and world-class clinical and medical standards. It also marks Diaverum's entry into Thessaloniki, the second largest city in Greece, expanding its footprint and offering enhanced dialysis services that significantly improve the quality of life for patients.
Commenting on the significance of the agreement, Dimitris Moulavasilis, Diaverum CEO, said: “This partnership marks a significant milestone in our mission to transform renal care in Greece. By combining Diaverum’s excellence in care standards and expertise in AI-enabled, personalised renal care, with BIOIATRIKI’s extensive collaborators' network, advanced diagnostic services, & strong local presence, we aim to deliver transformative solutions for dialysis patients, enabling access to world-class care”.
George Spanos, BIOIATRIKI's President & CEO, commented: “We are delighted to have entered into this agreement with Diaverum, a global leader in quality renal care services and a company that has swiftly established a strong and dynamic presence in Greece's renal care sector. This partnership reflects our Group's commitment, since our establishment in 1981, to delivering world-class healthcare services to our patients”.
Aris Bailan, Diaverum's Regional Director of Business Development for Europe & LatAm, added: “We are thrilled to be entering this agreement with BIOIATRIKI, which is driven by our shared vision to transform dialysis care. In combining BIOIATRIKI's strong local presence with Diaverum’s global expertise and innovative digital technologies, we look forward to empowering patients to live fulfilling lives, together”.
---
Marianna Sofocleous
Global Communications & Editorial Director
marianna.sofocleous@diaverum.com
About Diaverum
Diaverum is a Swedish-born, multinational healthcare organisation that provides life-enhancing renal care to patients with chronic kidney disease, empowering them to live fulfilling lives.
Our vision is to transform renal care, delivering and broadening access to the highest quality of kidney care for patients around the world. At the heart of what we do is our standardised care delivery model, continuously evolving digital & AI infrastructure and people caring for patients with competence, passion and inspiration.
As a global leader and the largest independent renal service provider in Europe, we have 13,000 healthcare professionals caring for around 41,000 patients across 450 clinics in 24 countries globally. We provide renal care personalised to patients’ needs and choices, offering a portfolio of treatments ranging from preventive care, haemodialysis, peritoneal dialysis and home care, to the coordination of patients’ comorbidities and holiday dialysis.
Founded in 1991 in Malmö, Sweden, Diaverum is part of the M42 group of companies, a first-of-its-kind integrated health powerhouse committed to the sustainable future of health.
